返回成功案例
医疗健康

Saideep Healthcare and Research has raised equity

Saideep Healthcare and Research Private Limited has successfully completed a fundraising. This funding will help Saideep become a leading healthcare brand, offering advanced specialties across the region. The funds from this collaboration will be used to diversify into new and complex specialties, expand infrastructure and meet the growing demand for high-quality healthcare services in Western India.

Saideep is a 260-bed multispecialty hospital based in Ahmednagar, Maharashtra, India, that has redefined healthcare delivery in the region since its inception in February 2019. This institution was founded through a collaborative effort by leading consultants in the city, who combined their expertise and resources to create a state-of-the-art facility.

Oaklins’ team in India advised the client on securing a strategic partner through an equity fundraise, and developed a strategy that led to a highly profitable exit for existing shareholders after four years.

联系交易团队

Parag Khadgi

合伙人
孟买, 印度
Oaklins VantagePoint

相关交易

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
医疗健康

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

更多信息
Afric Phar has been acquired by Pharma Capital
医疗健康

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

更多信息
Xiel Limited has been acquired by MIS Healthcare
私募基金 | 医疗健康

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

更多信息